Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-003766

VP Clinical Reg Affairs bought 250 shares at $20.84 ($5,210)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thompson Jaye VP Clinical Reg Affairs 2023-02-03 Purchase +250 $20.84 $5,210 257,245 D
Open-market purchases · 250 sh · avg $20.84 · $5,210
Loading xslF345X03/ownership.xml…